Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 482
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,463 Results (Page 4 of 124)
- Relevance
  Sort by

HIV Drugs Market Report by Drug Class, Distribution Channel, and Region 2024-2032

 Report
July 2024
142 Pages
Global

From

€3873EUR$3,899USD£3,221GBP

HIV Drugs Market By Medication Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

 Report
November 2023
35 Pages
Global

From

€3666EUR$3,690USD£3,048GBP

Megestrol Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
August 2023
110 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Sexually Transmitted Diseases (STDs) Drug - Global Strategic Business Report

 Report
November 2024
196 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Brain Hemorrhage - Pipeline Insight, 2024

 Clinical Trials
April 2024
75 Pages
Global

From

€1043EUR$1,050USD£867GBP

€1490EUR$1,500USD£1,239GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

 Report
June 2023
174 Pages
Global

From

€4620EUR$4,650USD£3,841GBP

HIV Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
82 Pages
Global

From

€1987EUR$2,000USD£1,652GBP

Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035

 Drug Pipelines
December 2022
30 Pages
Global

From

€1912EUR$1,925USD£1,590GBP

€2732EUR$2,750USD£2,271GBP

Bladder Cancer Therapeutics - Global Strategic Business Report

 Report
November 2024
283 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Progressive Multifocal Leukoencephalopathy Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
162 Pages
Global

From

€1987EUR$2,000USD£1,652GBP

Endometrial Cancer Treatment Market by Treatment, Grade, End-User - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Skin Cancer Diagnostics and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4719EUR$4,750USD£3,923GBP

Mitomycin C Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
April 2023
103 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Non-Melanoma Skin Cancer Treatment Market Report by Treatment Type, Indication, End Use, and Region 2024-2032

 Report
August 2024
144 Pages
Global

From

€3873EUR$3,899USD£3,221GBP

Generic Pharmaceuticals Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Ankylosing Spondylitis Market by Drug, Type of Molecule, Mechanism Of Action, Route Of Administration, Dosage Forms, End User - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

United States Skin Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
90 Pages
United States

From

€3477EUR$3,500USD£2,891GBP

Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

 Drug Pipelines
March 2023
150 Pages
Global

From

€10923EUR$10,995USD£9,082GBP

2,463 Results (Page 4 of 124)
- 1
- 2
- 3
- 4
- 5
- 6

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.